Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21202257 | 0.85 | — | — | |
| SCHEMBL15655854 | 0.75 | POLB (0.36) | POLBCYP1A2ACHE | |
| SCHEMBL9726278 | 0.75 | — | — | |
| SCHEMBL966903 | 0.73 | ACHE (0.41) | POLBACHE | |
| SCHEMBL965199 | 0.73 | ACHE (0.37) | POLBACHE | |
| SCHEMBL12121151 | 0.71 | IDO1 (0.35) | CYP1A2 | |
| SCHEMBL2458387 | 0.71 | ACHE (0.40) | POLBACHE | |
| SCHEMBL7548140 | 0.71 | ACHE (0.40) | POLBACHE | |
| SCHEMBL968768 | 0.71 | ACHE (0.35) | POLBACHE | |
| SCHEMBL8594481 | 0.69 | ACHE (0.39) | POLBACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101460064-A | Carotenoid-containing dietary supplement | CHEMAPHOR INC (CA) | 2009-06-17 | — | — | CN | claimed |
| EP-2007221-A1 | CAROTENOID-CONTAINING DIETARY SUPPLEMENT | Chemaphor Inc. (CA) | 2008-12-31 | — | — | EP | claimed |
| WO-2007112587-A1 | CAROTENOID-CONTAINING DIETARY SUPPLEMENT | CHEMAPHOR INC. (CA) | 2007-10-11 | — | — | WO | claimed |
| EP-3475256-B1 | DEHYDROGENATION REACTION | FIRMENICH & CIE (CH) | 2024-01-24 | — | — | EP | disclosed |
| CN-109415293-B | Dehydrogenation reaction | 弗门尼舍有限公司 | 2022-08-02 | — | — | CN | disclosed |
| US-10899694-B2 | Dehydrogenation reaction | FIRMENICH SA (CH) | 2021-01-26 | — | — | US | disclosed |
| US-20190345088-A1 | DEHYDROGENATION REACTION | FIRMENICH SA (CH) | 2019-11-14 | — | — | US | disclosed |
| US-20090306222-A1 | FOOD SUPPLEMENTS AND USES THEREOF | CHEMAPHOR INC. (CA) | 2009-12-10 | — | — | US | disclosed |
| CN-101460064-A | Carotenoid-containing dietary supplement | CHEMAPHOR INC (CA) | 2009-06-17 | — | — | CN | disclosed |
| EP-2007221-A1 | CAROTENOID-CONTAINING DIETARY SUPPLEMENT | Chemaphor Inc. (CA) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007112587-A1 | CAROTENOID-CONTAINING DIETARY SUPPLEMENT | CHEMAPHOR INC. (CA) | 2007-10-11 | — | — | WO | disclosed |
| EP-0449034-B1 | Cyclic ketones, method for their preparation and their application in perfumery | FIRMENICH & CIE (CH) | 1994-12-28 | — | — | EP | disclosed |
| US-5118865-A | CYCLIC KETONES AND THEIR USE AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 1992-06-02 | — | — | US | disclosed |
| EP-0449034-A1 | Cyclic ketones, method for their preparation and their application in perfumery | FIRMENICH SA (CH) | 1991-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10899694-B2 | Dehydrogenation reaction | PDK3, PDK2, PDHA1 | POLB 466/4885CYP1A2 53/4885ACHE 1798/4885 |
| US-20190345088-A1 | DEHYDROGENATION REACTION | PDK3, PDK2, PDHA1 | POLB 466/4885CYP1A2 53/4885ACHE 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.